Search
Patexia Research
Case number 1:17-cv-01554

iCeutica Pty Ltd. et al v. Apotex, Inc. et al > Documents

Date Field Doc. No.Description (Pages)
Jul 8, 2020 1 Complaint (20)
Jun 8, 2018 43 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,526,734 ;9,649,318. (dlb)
Jun 8, 2018 42 Stipulation of Dismissal (4)
Docket Text: STIPULATION of Dismissal by Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd.. (Hufnal, AnnaMartina)
Jun 8, 2018 N/A Terminated Case (0)
Docket Text: CASE CLOSED (dlb)
Jun 5, 2018 N/A SO ORDERED (0)
Docket Text: SO ORDERED D.I. [41] STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Response to Amended Complaint to June 19, 2018 filed by Apotex, Inc., Apotex Corp. Ordered by Judge Christopher J. Burke on 6/5/2018. (dlb)
Jun 4, 2018 41 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Response to Amended Complaint to June 19, 2018 - filed by Apotex Corp., Apotex, Inc.. (Haney, Megan)
May 22, 2018 40 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for defendants Apotex Inc. and Apotex Corp. to answer, move or otherwise respond to the Amended Complaint (D.I. 39) to June 5, 2018 - filed by Apotex Corp., Apotex, Inc.. (Haney, Megan)
May 22, 2018 N/A SO ORDERED (0)
May 8, 2018 39 Amended Complaint* (1)
May 8, 2018 39 Main Document (26)
Docket Text: AMENDED COMPLAINT against Apotex Corp., Apotex, Inc.- filed by Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(dlb)
May 8, 2018 38 Main Document (2)
Docket Text: STIPULATION to Allow Plaintiffs to file an Amended Complaint by Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd.. (Attachments: # (1) Exhibit 1 - Amended Complaint, # (2) Exhibit 2 - Redlined Amended Complaint)(Winter, Christopher)
May 8, 2018 39 Exhibit C (19)
May 8, 2018 39 Exhibit B (17)
May 8, 2018 39 Exhibit A (17)
May 8, 2018 39 Amended Complaint (26)
May 8, 2018 38 Exhibit 2 - Redlined Amended Complaint (26)
May 8, 2018 38 Exhibit 1 - Amended Complaint (78)
May 8, 2018 38 Stipulation (2)
May 8, 2018 N/A SO ORDERED (0)
Apr 30, 2018 37 Notice (Other) (2)
Docket Text: NOTICE of Change of Law Firm by Apotex Corp., Apotex, Inc. (Phillips, John)
Apr 20, 2018 36 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Apotex, Inc. and Apotex, Corp.'s Initial Invalidity Contentions filed by Apotex Corp., Apotex, Inc..(Bilson, David)
Apr 18, 2018 35 Order Setting Teleconference (4)
Docket Text: ORDER Setting Teleconference: plaintiffs counsel shall initiate the call. A Telephone Conference is set for 4/30/2018 at 11:30 AM before Judge Sherry R. Fallon to discuss ADR. Signed by Judge Sherry R. Fallon on 4/18/2018. Associated Cases: 1:17-cv-01553-VAC-CJB, 1:17-cv-01554-VAC-CJB(lih)
Apr 17, 2018 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Magistrate Judge Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-01553-VAC-CJB, 1:17-cv-01554-VAC-CJB(lih)
Apr 10, 2018 34 Letter (1)
Docket Text: Letter to Honorable Christopher J. Burke from Martina Tyreus Hufnal regarding mediating judge. (Hufnal, AnnaMartina)
Apr 3, 2018 N/A SO ORDERED (0)
Mar 29, 2018 33 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for defendants Apotex Inc. and Apotex Corp. to produce initial invalidity contentions to April 20, 2018 - filed by Apotex Corp., Apotex, Inc.. (Phillips, John)
Mar 16, 2018 32 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts filed by Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd..(Winter, Christopher)
Mar 15, 2018 31 Order Setting Mediation Conferences (5)
Docket Text: ORDER Setting Mediation Conference: A Telephone Conference is set for 4/30/2018 at 11:15 AM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 3/15/2018. (dlb)
Mar 15, 2018 30 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of iCeutica Pty Ltd and Iroko Pharmaceuticals, LLCs Initial Disclosures Pursuant To Paragraph 3 of the District of Delaware Default Standard For Discovery filed by Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd..(Winter, Christopher)
Mar 14, 2018 29 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants Apotex, Inc. and Apotex, Corp.'s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Apotex Corp., Apotex, Inc..(Bilson, David)
Feb 26, 2018 N/A SO ORDERED (0)
Feb 23, 2018 N/A SO ORDERED (0)
Feb 23, 2018 28 Proposed Order (22)
Docket Text: PROPOSED ORDER Stipulated Proposed Protective Order by Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd.. (Winter, Christopher)
Feb 23, 2018 27 Proposed Order (21)
Docket Text: PROPOSED ORDER Protective Order by Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd.. (Winter, Christopher)
Feb 23, 2018 26 Stipulation (2)
Docket Text: STIPULATION extend time to serve initial infringement and invalidity contentions by Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd.. (Winter, Christopher)
Feb 23, 2018 N/A Oral Order (0)
Docket Text: ORAL ORDER: Parties shall submit, by no later than February 28, 2018, a revised version of the D.I. 27 Proposed Protective Order that contains the paragraph listed in Section 3 the Scheduling Order (D.I. 23) entered in this case. Ordered by Judge Christopher J. Burke on 2/23/2018. (dlb)
Feb 20, 2018 25 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Fe. R. Civ. P. 26(a) Initial Disclosures filed by Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd..(Winter, Christopher)
Feb 20, 2018 24 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants Apotex, Inc. and Apotex Corp.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Apotex Corp., Apotex, Inc..(Bilson, David)
Feb 14, 2018 N/A Case Referred to Mediation (0)
Feb 13, 2018 23 Scheduling Order (16)
Docket Text: SCHEDULING ORDER: Joinder of Parties due by 11/21/2018. Amended Pleadings due by 11/21/2018. Discovery due by 2/15/2019. Opening Expert Reports due by 4/12/2019. Rebuttal Expert Reports due by 5/10/2019. Expert Discovery due by 7/12/2019. Status Report due by 12/21/2018. Dispositive Motions due by 7/26/2019. A Motion Hearing is set for 8/28/2019 at 02:00 PM before Vacant Judgeship (2017) Claim Construction Opening Brief due by 10/19/2018. Claim Construction Answering Brief due by 11/16/2018. Claim Construction Reply Brief due by 12/14/2018. Claim Construction Surreply Brief due by 1/4/2019. A Markman Hearing is set for 1/30/2019 at 01:00 PM before Vacant Judgeship (2017). A Pretrial Conference is set for 10/23/2019 at 01:00 PM before Vacant Judgeship (2017). A Bench Trial is set for 11/18/2019 at 09:30 AM before Vacant Judgeship (2017). Signed by Judge Christopher J. Burke on 2/13/2018. (dlb)
Feb 12, 2018 N/A Scheduling Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Case Management/Scheduling Conference held on 2/12/2018. The Court discussed the schedule with the parties and provided key dates. The Court will enter the Proposed Order as discussed during the conference. (Clerk, D. Benyo) APPEARANCES: M. Hufnal for Plaintiffs; B. Bilson for Defendants. By phone - M. Chacon for Plaintiffs; J. Janusz for Defendants. (Court Reporter Taneha Carroll (Hawkins Reporting)) (dlb)
Feb 9, 2018 21 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Apotex's Production of Core Technical Documents Pursuant to Paragraph 7(b) of the Proposed Scheduling Order filed by Apotex Corp., Apotex, Inc..(Haney, Megan)
Feb 9, 2018 22 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiff's Identification of Accused Products, Damages Model, and Asserted Patents Pursuant to Paragraph 7(a) of the Proposed Scheduling Order filed by Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd..(Hufnal, AnnaMartina)
Feb 8, 2018 20 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by Christopher Aylwin Winter on behalf of Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd. (Winter, Christopher)
Jan 30, 2018 19 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by David A. Bilson on behalf of Apotex Corp., Apotex, Inc. (Bilson, David)
Jan 10, 2018 N/A Order Setting Scheduling Conference (0)
Docket Text: Order Setting Telephonic Case Management/Scheduling Conference: A Case Management/Scheduling Conference is set for 2/12/2018 at 03:00* PM before Judge Christopher J. Burke. Because the proposed order is without any disputes, only Delaware counsel should appear in person. Outside counsel may participate telephonically. *This Case Management Conference will begin immediately after the conclusion of the Case Management Conference in Civil Action No. 17-cv-1553-VAC-CJB. Ordered by Judge Christopher J. Burke on 1/10/2018. (dlb)
Jan 9, 2018 17 Letter (2)
Jan 9, 2018 17 Main Document (2)
Docket Text: Letter to Honorable Christopher J. Burke from Martina Tyreus Hufnal regarding Case Management. (Attachments: # (1) Case Management Checklist)(Hufnal, AnnaMartina)
Jan 9, 2018 18 Proposed Order (16)
Docket Text: PROPOSED ORDER Scheduling Order by Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd.. (Hufnal, AnnaMartina)
Jan 9, 2018 17 Case Management Checklist (3)
Dec 20, 2017 16 Answer to Counterclaim (4)
Docket Text: ANSWER to [9] Answer to Complaint, Counterclaim by Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd..(Hufnal, AnnaMartina)
Dec 18, 2017 N/A Add Attorneys Pro Hac Vice (0)
Dec 18, 2017 N/A SO ORDERED (0)
Dec 18, 2017 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Megan A. Chacon for Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-01554-VAC-CJB, 1:17-cv-01553-VAC-CJB(crb)
Dec 15, 2017 15 Stipulation (2)
Docket Text: Joint STIPULATION to extend the time to file Court's Case Management Checklist, Proposed Scheduling Order and case letter until January 9, 2018 by Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd.. (Hufnal, AnnaMartina)
Dec 13, 2017 N/A Add Attorneys Pro Hac Vice (0)
Dec 6, 2017 N/A SO ORDERED (0)
Dec 5, 2017 14 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by William Chad Shear on behalf of Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd. (Shear, William)
Dec 5, 2017 13 Motion for Leave to Appear Pro Hac Vice (3)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Megan A. Chacon - filed by Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd.. Motions referred to Christopher J. Burke.(Hufnal, AnnaMartina)
Dec 1, 2017 12 Motion for Leave to Appear Pro Hac Vice (5)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Deepro Mukerjee, Lance Soderstrom, Joseph M. Janusz and Stephanie M. Roberts - filed by Apotex Corp., Apotex, Inc.. Motions referred to Christopher J. Burke.(Haney, Megan)
Nov 30, 2017 N/A Oral Order (0)
Nov 30, 2017 11 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by Megan C. Haney on behalf of Apotex Corp., Apotex, Inc. (Haney, Megan)
Nov 29, 2017 10 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings Inc. for Apotex Corp., Apotex, Inc. filed by Apotex Corp., Apotex, Inc.. (Phillips, John)
Nov 29, 2017 9 Answer to Complaint (17)
Docket Text: ANSWER to [1] Complaint, Affirmative Defenses and, COUNTERCLAIM against Iroko Pharmaceuticals, LLC, iCeutica Pty Ltd. by Apotex Corp., Apotex, Inc..(Phillips, John)
Nov 10, 2017 8 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by iCeutica Pty Ltd., Iroko Pharmaceuticals, LLC: For Apotex Corp. waiver sent on 11/8/2017, answer due 1/8/2018. (Hufnal, AnnaMartina)
Nov 10, 2017 7 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by iCeutica Pty Ltd., Iroko Pharmaceuticals, LLC: For Apotex, Inc. waiver sent on 11/8/2017, answer due 1/8/2018. (Hufnal, AnnaMartina)
Nov 8, 2017 N/A Remark (0)
Docket Text: REMARK: If the parties jointly consent to have a Magistrate Judge conduct all proceedings in this case, including trial, then when Judge Burke enters a case schedule he will enter the respective pre-trial conference and trial dates onto his calendar and will honor them. Otherwise, in accordance with the District Court's procedures for "Assignment of Cases to Visiting Judges" (issued on May 26, 2017 and available on the District Court's website), then upon the filing of a case-dispositive motion (e.g., a motion to dismiss, a motion for judgment on the pleadings, a motion for summary judgment, or initiation of the claim construction process in a patent case), VAC cases will be considered ready for reassignment to a visiting District Judge. Whether the pre-trial conference and trial dates will stand after reassignment will depend on the availability of those dates on the visiting District Judge's calendar. Associated Cases: 1:17-cv-01553-VAC-CJB, 1:17-cv-01554-VAC-CJB(dlb)
Nov 8, 2017 N/A Remark re Newer Attorneys (0)
Docket Text: REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/default/files/forms/StandingOrder2017.pdf Associated Cases: 1:17-cv-01553-VAC-CJB, 1:17-cv-01554-VAC-CJB(dlb)
Nov 8, 2017 N/A Case Referred to Magistrate Judge (0)
Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) Associated Cases: 1:17-cv-01553-VAC-CJB, 1:17-cv-01554-VAC-CJB (rjb)
Nov 8, 2017 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Vacant Judgeship (2017). Please include initials of VAC after the case number on all documents filed. Associated Cases: 1:17-cv-01553-VAC, 1:17-cv-01554-VAC (rjb)
Nov 1, 2017 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Apotex Corp. on 11/1/2017; Apotex, Inc. on 11/1/2017. (jcs)
Nov 1, 2017 N/A No Summons Issued (0)
Docket Text: No Summons Issued. (jcs)
Oct 31, 2017 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent iCeutica Inc. for iCeutica Pty Ltd. filed by iCeutica Pty Ltd. (jcs)
Oct 31, 2017 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,526,734; 9,649,318. (jcs)
Oct 31, 2017 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 21, 2017. Date of Expiration of Patent: March 31, 2033.Thirty Month Stay Deadline: 3/21/2020. (jcs)
Oct 31, 2017 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs)
Oct 31, 2017 1 Civil Cover Sheet (1)
Oct 31, 2017 1 Exhibit B (17)
Oct 31, 2017 1 Exhibit A (17)
Oct 31, 2017 1 Main Document (20)
Docket Text: COMPLAINT filed with Jury Demand against Apotex Corp., Apotex, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2256791.) - filed by iCeutica Pty Ltd., Iroko Pharmaceuticals, LLC. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Civil Cover Sheet)(jcs)
Oct 31, 2017 6 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Iroko Intermediate Holdings, Inc. for Iroko Pharmaceuticals, LLC filed by Iroko Pharmaceuticals, LLC. (jcs)
Oct 31, 2017 1 Complaint* (1)
Menu